Komori
Share Issuance and Disposal4506Sumitomo Pharma Co.,Ltd.Pharmaceuticals

Notice Regarding the Results of the Third-Party Allocation of Shares (Not Implemented)

The planned issuance of new shares through a third-party allotment, which had already been approved, was not carried out because the allottee did not submit an application, and none of the planned shares were issued.

Worth reading
69In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
7695600
Shares (number of shares not issued)
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of new shares through a third-party allotment (not implemented)

Who receives how much

Initially planned issuance: 7,695,600 shares; actual issuance: 0 shares

SMBC Nikko Securities Inc. (7,695,600 shares; no application submitted)

The lower thin line represents the existing number of shares to which these shares will be added.

Offering structure
Underwriter / lead underwriter
SMBC Nikko Securities Inc.
Overallotment
An over-allotment secondary offering was also approved at the same time, but details other than the number of shares offered and the maximum number of shares under the third-party allotment are not disclosed
Most recent equity financing
Issuance of new shares through a third-party allotment approved at the same time as the public offering of new shares and secondary offering approved on 8 April 2026 (amount not disclosed in this filing)
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of new shares through a third-party allotment (not implemented)
Number of shares to be issued or disposed ofInitially planned issuance: 7,695,600 shares; actual issuance: 0 shares
Intended allotteeSMBC Nikko Securities Inc. (7,695,600 shares; no application submitted)
Underwriter / lead underwriterSMBC Nikko Securities Inc.
OverallotmentAn over-allotment secondary offering was also approved at the same time, but details other than the number of shares offered and the maximum number of shares under the third-party allotment are not disclosed
Most recent equity financingIssuance of new shares through a third-party allotment approved at the same time as the public offering of new shares and secondary offering approved on 8 April 2026 (amount not disclosed in this filing)
Items this document does not state (22)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceExercise periodNumber of Stock Acquisition RightsTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

SMBC Nikko Securities Inc., the allottee, notified the company that it would not apply for any of the shares by the application deadline.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Results of the Third-Party Allocation of Shares (Not Implemented) | Sumitomo Pharma Co.,Ltd. (4506) timely disclosure | Komori